国家自然科学基金:靶向FAK/PLK1双靶点抑制剂的发现与抗肿瘤转移活性研究(No.22107092)
浙江省自然科学基金:新型双靶点 FAK/PLK1 抑制剂的设计、合成及抗肿瘤作用机制研究(No.LQ20B020001)
山东省自然科学基金:靶向PPARγ的甘草次酸类衍生物的设计、合成及生物活性研究(No.ZR2018BH040)
Sun J, Liu HY, Zhang YH, Fang ZY, Lv PC*. Design, synthesis and bioactivity evaluation of thiazolidinedione derivatives as partial agonists targeting PPARγ. Bioorganic Chemistry, 2021, 116,105342.
Sun J, Chen YH, Liu HY, Hondo E, Zhou Y*, Wu YF*. Thiazolidinedione: A Privileged Scaffold for the Development of Anticancer Agents. Current Topics in Medicinal Chemistry, 2021, 21, 2529-2545.
Wu SM, Qiu XY, Liu SJ, Sun J*. Single Heterocyclic Compounds as Monoamine Oxidase Inhibitors: From Past to Present. Mini-Reviews in Medicinal Chemistry, 2020, 20, 908-920.
Sun J, Liu HY, Lv CZ, Qin J, Wu YF*. Modification, Antitumor Activity, and Targeted PPARγ Study of 18β-Glycyrrhetinic Acid, an Important Active Ingredient of Licorice. Journal of Agricultural and Food Chemistry, 2019, 67(34), 9643-9651.
Sun J, He W, Liu HY, Qin J, Ye CL*. Design, synthesis and molecular docking of 1,4-benzodioxane thiazolidinedione piperazine derivatives as FabH inhibitors. Bioorganic Chemistry, 2019, 88, 102958.
Liu HY, Wang TR, Sheng GH, Qin J, Sun J*. Synthesis, Biological Evaluation, and Molecular Docking of 1,4-Benzodioxan Derivatives as Potential Antibacterial Agents. Russian Journal of General Chemistry, 2018, 88(12):2601-2610.
Sun J, Liu HY, Xu RF, Zhu HL*. Identification of nitroimidazole-oxime derivatives targeting the polo-box domain of polo-like kinase 1. Bioorganic & Medicinal Chemistry, 2017, 25, 6581-6588.
Sun J, Ren SZ , Lu XY, Li JJ, Shen FQ, Xu C, Zhu HL*. Discovery of a series of 1,3,4-oxadiazole-2(3 H )-thione derivatives containing piperazine skeleton as potential FAK inhibitors. Bioorganic & Medicinal Chemistry, 2017, 25(9):2593-2600.
Sun J, Lv PC, Zhu HL*. Tyrosyl-tRNA synthetase inhibitors: a patent review. Expert Opinion on Therapeutic Patents, 2017, 27(1-6):557-564.
孙娟,刘汉宇,朱海亮,杨永安,郝美茹,左婧。含哌嗪结构的甘草次酸类衍生物及其制备方法与用途。授权号:ZL201810526145.3。
孙娟,常青,朱国峰,王玉婷,杨忠梅,曾丽。一种哌嗪衍生物及其制备方法与用途。授权号:ZL201710341649.3。
孙娟,朱海亮,连志敏,王苏,刘汉宇。靛红酰肼类衍生物及其制备方法。授权号:ZL201610510449.1。
孙娟,连志敏,朱海亮,徐以增,孙丽芹,高磊磊。含有噁二唑的哌嗪衍生物及其制备方法和用途。授权号:ZL201610259548.7。